Lck inhibitor II

• CAT Number: I030587
• CAS Number: 918870-43-6
• Molecular Formula: C24H26N6O3
• Molecular Weight: 446.51
• Purity: 98%
• Synonyms: Lck inhibitor II; 3-(2-(1H-Benzo[d]imidazol-1-yl)-6-(2-morpholinoethoxy)-pyrimidin-4-ylamino)-4-methylphenol.
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 3-(2-(1H-Benzo[d]imidazol-1-yl)-6-(2-morpholinoethoxy)-pyrimidin-4-ylamino)-4-methylphenol
• InChI: InChI=1S/C24H26N6O3/c1-17-6-7-18(31)14-20(17)26-22-15-23(33-13-10-29-8-11-32-12-9-29)28-24(27-22)30-16-25-19-4-2-3-5-21(19)30/h2-7,14-16,31H,8-13H2,1H3,(H,26,27,28)
• InChIKey: DKDNLOIZODSWFH-UHFFFAOYSA-N
• SMILES: OC1=CC=C(C)C(NC2=NC(N3C=NC4=CC=CC=C34)=NC(OCCN5CCOCC5)=C2)=C1

Lck inhibitor II is a cell-permeable, ATP binding site-targeting, tri-substituted pyrimidine that acts as a highly potent Lck (lymphocyte specific kinase) inhibitor

Reference

1: Zepecki JP, Snyder KM, Moreno MM, Fajardo E, Fiser A, Ness J, Sarkar A, Toms SA, Tapinos N. Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor. Oncogene. 2019 Mar;38(10):1734-1750. doi: 10.1038/s41388-018-0546-z. Epub 2018 Oct 23. PubMed PMID: 30353164.
2: Fu X, Xu M, Song Y, Li Y, Zhang H, Zhang J, Zhang C. Enhanced interaction between SEC2 mutant and TCR Vβ induces MHC II-independent activation of T cells via PKCθ/NF-κB and IL-2R/STAT5 signaling pathways. J Biol Chem. 2018 Dec 21;293(51):19771-19784. doi: 10.1074/jbc.RA118.003668. Epub 2018 Oct 23. PubMed PMID: 30352872; PubMed Central PMCID: PMC6314126.
3: Arranz-Nicolás J, Ogando J, Soutar D, Arcos-Pérez R, Meraviglia-Crivelli D, Mañes S, Mérida I, Ávila-Flores A. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals. Cancer Immunol Immunother. 2018 Jun;67(6):965-980. doi: 10.1007/s00262-018-2154-8. Epub 2018 Mar 23. PubMed PMID: 29572701.
4: Amengual JE, Prabhu SA, Lombardo M, Zullo K, Johannet PM, Gonzalez Y, Scotto L, Serrano XJ, Wei Y, Duong J, Nandakumar R, Cremers S, Verma A, Elemento O, O’Connor OA. Mechanisms of Acquired Drug Resistance to the HDAC6 Selective Inhibitor Ricolinostat Reveals Rational Drug-Drug Combination with Ibrutinib. Clin Cancer Res. 2017 Jun 15;23(12):3084-3096. doi: 10.1158/1078-0432.CCR-16-2022. Epub 2016 Dec 19. PubMed PMID: 27993968; PubMed Central PMCID: PMC5474138.
5: Marech I, Patruno R, Zizzo N, Gadaleta C, Introna M, Zito AF, Gadaleta CD, Ranieri G. Masitinib (AB1010), from canine tumor model to human clinical development: where we are? Crit Rev Oncol Hematol. 2014 Jul;91(1):98-111. doi: 10.1016/j.critrevonc.2013.12.011. Epub 2013 Dec 17. Review. PubMed PMID: 24405856.
6: Wan CP, Gao LX, Hou LF, Yang XQ, He PL, Yang YF, Tang W, Yue JM, Li J, Zuo JP. Astragaloside II triggers T cell activation through regulation of CD45 protein tyrosine phosphatase activity. Acta Pharmacol Sin. 2013 Apr;34(4):522-30. doi: 10.1038/aps.2012.208. Epub 2013 Mar 25. PubMed PMID: 23524573; PubMed Central PMCID: PMC4002795.
7: Joosten M, Seitz V, Zimmermann K, Sommerfeld A, Berg E, Lenze D, Leser U, Stein H, Hummel M. Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. Haematologica. 2013 Feb;98(2):247-54. doi: 10.3324/haematol.2011.054619. Epub 2012 Aug 16. PubMed PMID: 22899583; PubMed Central PMCID: PMC3561432.
8: Guckel D, Ciarimboli G, Pavenstädt H, Schlatter E. Regulation of organic cation transport in isolated mouse proximal tubules involves complex changes in protein trafficking and substrate affinity. Cell Physiol Biochem. 2012;30(1):269-81. doi: 10.1159/000339063. Epub 2012 Jun 19. PubMed PMID: 22759973.
9: Kahan BD. Frontiers in immunosuppression. Transplant Proc. 2011 Apr;43(3):822-5. doi: 10.1016/j.transproceed.2011.02.001. PubMed PMID: 21486607.
10: Pacey S, Wilson RH, Walton M, Eatock MM, Hardcastle A, Zetterlund A, Arkenau HT, Moreno-Farre J, Banerji U, Roels B, Peachey H, Aherne W, de Bono JS, Raynaud F, Workman P, Judson I. A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res. 2011 Mar 15;17(6):1561-70. doi: 10.1158/1078-0432.CCR-10-1927. Epub 2011 Jan 28. Erratum in: Clin Cancer Res. 2018 Nov 1;24(21):5488. PubMed PMID: 21278242; PubMed Central PMCID: PMC3060938.
11: Su Y, Jackson EK, Gorelik E. Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes. Cancer Immunol Immunother. 2011 Jan;60(1):111-22. doi: 10.1007/s00262-010-0924-z. Epub 2010 Oct 20. PubMed PMID: 20960188; PubMed Central PMCID: PMC3107516.
12: Sakai H, Nishimura A, Watanabe Y, Nishizawa Y, Hashimoto Y, Chiba Y, Misawa M. Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle. Peptides. 2010 Dec;31(12):2216-21. doi: 10.1016/j.peptides.2010.09.012. Epub 2010 Sep 21. PubMed PMID: 20863867.
13: Yagi YI, Abe K, Ikebukuro K, Sode K. Kinetic mechanism and inhibitor characterization of WNK1 kinase. Biochemistry. 2009 Nov 3;48(43):10255-66. doi: 10.1021/bi900666n. PubMed PMID: 19739668.
14: Jecklin MC, Touboul D, Jain R, Toole EN, Tallarico J, Drueckes P, Ramage P, Zenobi R. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurements. Anal Chem. 2009 Jan 1;81(1):408-19. doi: 10.1021/ac801782c. PubMed PMID: 19067573.
15: Chow KU, Nowak D, Trepohl B, Hochmuth S, Schneider B, Hoelzer D, Mitrou PS, Bergmann L, Ottmann OG, Boehrer S. The tyrosine kinase inhibitor AMN107 (Nilotinib) exhibits off-target effects in lymphoblastic cell lines. Leuk Lymphoma. 2007 Jul;48(7):1379-88. PubMed PMID: 17613767.
16: Jackson EK, Gillespie DG, Jackson TC. Phospholipase C and Src modulate angiotensin II-induced cyclic AMP production in preglomerular microvascular smooth-muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2007 Feb;49(2):106-10. PubMed PMID: 17312452.
17: Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, Milione M, Bhakta V, Campanini N, Swift SM, Bordi C, Delle Fave G, Lemoine NR. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr Relat Cancer. 2006 Jun;13(2):541-58. PubMed PMID: 16728581.
18: Masci AM, Galgani M, Cassano S, De Simone S, Gallo A, De Rosa V, Zappacosta S, Racioppi L. HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling. J Leukoc Biol. 2003 Dec;74(6):1117-24. Epub 2003 Sep 12. PubMed PMID: 12972513.
19: Kobayashi K, Nakashima A, Nagata H, Nakajima H, Yamaguchi K, Sato S, Miki I. Anti-arthritic effects of KF20444, a new immunosuppressive compound inhibiting dihydroorotate dehydrogenase, on rat collagen-induced arthritis. Inflamm Res. 2001 Jan;50(1):24-31. PubMed PMID: 11235018.
20: Kang KR, Kim CW. Regulation of chicken protein tyrosine phosphatase 1 and human protein tyrosine phosphatase 1B activity by casein kinase II- and p56lck-mediated phosphorylation. Exp Mol Med. 2000 Mar 31;32(1):47-51. PubMed PMID: 10762062.